Acne 

Actinic Keratosis 

Allergy

Anti-Aging

Atopic Dermatitis 

BPDCN

COVID-19

Diabetes 

Dry Cracked Skin

Examining Nature-Based Skincare

Fibroids

Hair & Scalp

Hidradentitis Suppurativa

Impetigo

Inflamed Skin

Melasma

Pediatric Dermatology

Pigmentary Disorders 

Precision Medicine and Biologics

Psoriasis 

Psoriatic Arthritis 

Rare Disease

Rosacea 

Skin Cancer

Surgery

The Evolution of Aesthetics

Vitiligo

Women's Health

Wound Care

News

Device Technology

Drug Watch

Legal

Lifestyle

NP and PA

Practice Management 

Media

2 Minute Drill

Around the Practice

Between The Lines

Case Based Peer Perspective

Dermview

Dermview: Vitiligo

Editorial Board News

Expert Interviews

Frontline Forum

Inside the Clinic

Medical World News

Podcasts

Readout360

Recognize and Refer

Viewpoints

Webinars

Conferences

Conference Coverage

Conference Listing

Publication

Dermatology Times

CME/CE

Resources

Image IQ

Interactive Tools

Job Board

Partnerships

Polls

Editorial Board

Subscribe

Print Subscription

eNewsletter

Articles

Newly released safety and efficacy data on Novartis’ secukinumab for hidradenitis suppurativa is published in The Lancet.  

HS Treatment Response Rates Continue to Improve with Secukinumab at Week 52

ICYMI, this week we had stories about adalimumab biosimilars, an expanded Banana Boat Hair & Scalp Sunscreen recall, what's trending in skin care for January 2023, and more. 

The Weekly Roundup: January 30-February 3 

Dr. Goldberg is Director of Skin Laser & Surgery Specialists of New York and New Jersey, Director of Mohs Surgery and laser research, Mt. Sinai School of Medicine, and Adjunct Professor of Law, Fordham Law School.

This month's Legal Eagle column explores what information is required during an informed consent discussion. 

Losing a Malpractice Case May Depend on Where You Live  

Atopic dermatitis is not a "one-size-fits-all" condition. 

10 Things I Wish My Patients Knew About Atopic Dermatitis

Advertise

Contact Us

Do Not Sell My Information

Terms and Conditions

Privacy Policy

Dermatology Times and Multimedia Medical, LLC

Twitter

Facebook

Linkedin

Topics

Acne

Rosacea

Skin Cancer (Melanoma)

Skin Cancer (Non-Melanoma)

1rem

View

Poll

Polls 

POLL: Has your practice seen a rise in aesthetic procedures since the start of the pandemic?

POLL: Has your practice seen a rise in aesthetic procedures since the start of the pandemic?

POLL: Which Adalimumab Biosimilar Will be Available First in 2023?

POLL: Approximately How Many Nurse Practitioners are in the US?

POLL: Are You Attending Winter Clinical Hawaii?

POLL: Which Adalimumab Biosimilar Will be Available First in 2023?

POLL: Approximately How Many Nurse Practitioners are in the US?

POLL: Are You Attending Winter Clinical Hawaii?

POLL: Which Adalimumab Biosimilar Will be Available First in 2023?

POLL: Approximately How Many Nurse Practitioners are in the US?

POLL: Are You Attending Winter Clinical Hawaii?